Crossing the blood-brain barrier: advances in nanoparticle technology for drug delivery in neuro-oncology

AM Hersh, S Alomari, BM Tyler - International journal of molecular …, 2022 - mdpi.com
The blood-brain barrier (BBB) constitutes a microvascular network responsible for excluding
most drugs from the brain. Treatment of brain tumors is limited by the impermeability of the …

Recent advances in biosensor development for the detection of cancer biomarkers

VSA Jayanthi, AB Das, U Saxena - Biosensors and Bioelectronics, 2017 - Elsevier
Cancer is the second largest disease throughout the world with an increasing mortality rate
over the past few years. The patient's survival rate is uncertain due to the limitations of …

Various types of electrochemical biosensors for leukemia detection and therapeutic approaches

S Chupradit, MKM Nasution, HS Rahman… - Analytical …, 2022 - Elsevier
Leukemia often initiates following dysfunctions in hematopoietic stem cells lineages. Various
types of leukemia, including acute lymphoblastic leukemia (ALL), chronic myelogenous …

Iron in the tumor microenvironment—connecting the dots

C Pfeifhofer-Obermair, P Tymoszuk, V Petzer… - Frontiers in …, 2018 - frontiersin.org
Iron metabolism and tumor biology are intimately linked. Iron facilitates the production of
oxygen radicals, which may either result in iron-induced cell death, ferroptosis, or contribute …

Quantum dots: The cutting-edge nanotheranostics in brain cancer management

P Chakraborty, SS Das, A Dey, A Chakraborty… - Journal of Controlled …, 2022 - Elsevier
Quantum dots (QDs) are semiconductor nanocrystals possessing unique optoelectrical
properties in that they can emit light energy of specific tunable wavelengths when excited by …

Potential of nanocarrier-based drug delivery systems for brain targeting: A current review of literature

BS Alotaibi, M Buabeid, NA Ibrahim… - International Journal …, 2021 - Taylor & Francis
The advent of nanotechnologies such as nanocarriers and nanotherapeutics has changed
the treatment strategy and developed a more efficacious novel drug delivery system. Various …

Intraoperative fluorescence imaging for personalized brain tumor resection: current state and future directions

E Belykh, NL Martirosyan, K Yagmurlu, EJ Miller… - Frontiers in …, 2016 - frontiersin.org
Introduction Fluorescence-guided surgery is one of the rapidly emerging methods of surgical
“theranostics.” In this review, we summarize current fluorescence techniques used in …

Advancing glioblastoma treatment through iron metabolism: A focus on TfR1 and Ferroptosis innovations

MD Caverzan, LE Ibarra - International Journal of Biological …, 2024 - Elsevier
Glioblastoma (GBM) represents a formidable challenge in oncology, characterized by
aggressive proliferation and poor prognosis. Iron metabolism plays a critical player in GBM …

Nanoparticle strategies to improve the delivery of anticancer drugs across the blood–brain barrier to treat brain tumors

WJF Vanbilloen, JS Rechberger, JB Anderson… - Pharmaceutics, 2023 - mdpi.com
Primary brain and central nervous system (CNS) tumors are a diverse group of neoplasms
that occur within the brain and spinal cord. Although significant advances in our …

Natural polymeric nanoparticles for brain-targeting: implications on drug and gene delivery

AO Elzoghby, MM Abd-Elwakil… - Current …, 2016 - ingentaconnect.com
There is a broad range of biological, chemical and physical hurdles for drugs to reach the
brain. Nanoparticulate drug delivery systems hold tremendous potential for diagnosis and …